ArticleThe pharmacogenomics journal2020

Polymorphisms of NF-κB pathway genes influence adverse drug reactions of gefitinib in NSCLC patients.

Shuang Xin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.